Impact of Coronavirus Disease 2019 Restrictions on Retinal Detachment: A Multicenter Experience.

PubMed ID: 35144021

Author(s): Jung JJ, Chang JS, Oellers PR, Ali MH, Do BK, Tseng JJ, Roizenblatt R, Muni RH, Weng CY, Oakey ZB, Tsao SW, Rofagha S, Chan X, Hoang QV; Young Retina Forum. Impact of Coronavirus Disease 2019 Restrictions on Retinal Detachment: A Multicenter Experience. Ophthalmol Retina. 2022 Jul;6(7):638-641. doi: 10.1016/j.oret.2022.02.001. Epub 2022 Feb 7. PMID 35144021

Journal: Ophthalmology. Retina, Volume 6, Issue 7, Jul 2022

In this retrospective, multicenter study of 261 eyes (259 patients), patients who underwent rhegmatogenous retinal detachment repair during the coronavirus disease 2019 (COVID-19) post-lockdown period experienced an additional 22-day delay, leading to significantly more epiretinal membrane and proliferative vitreoretinopathy and lower single-surgery anatomic success rates. During lockdown, perfluoropropane gas was used more commonly, and pneumatic retinopexy was used more commonly in COVID-19-positive patients.

Copyright © 2022 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.